Patent · US Active

Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders

US8415385B2 · kind B2 · utility

0Cited by

8References

6Claims

0Family size

Inventors

Hao Chen · Columbia, US
Ming-Sun Liu · Brea, US
Qi Su · Shanghai, CN
Manish Raisinghani · Jamesburg, US

Key dates

Filing date	Jul 12, 2011
Grant date	Apr 9, 2013
Priority date	—
Expiry date	Jul 12, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.